Detecting cognitive impairment in underserved communities using health technologies
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
NA · Northwestern University · NCT05607732
This study tests if using an iPad-based tool to check for memory problems can help doctors better care for older adults from underserved communities compared to regular check-ups.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 45257 (estimated) |
| Ages | 45 Years and up |
| Sex | All |
| Sponsor | Northwestern University (other) |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT05607732 on ClinicalTrials.gov |
What this trial studies
This study aims to improve the detection and management of cognitive impairment and dementia in primary care settings, particularly among underserved populations. It employs a clinic-randomized, pragmatic trial design to compare the effectiveness of the MyCog paradigm, which utilizes an iPad-based assessment linked to electronic health records, against usual care. The focus is on older adults from low socioeconomic backgrounds and minority groups, with the goal of providing actionable recommendations for care planning and management. The trial is conducted in partnership with Oak Street Health, targeting real-world applicability and sustainability.
Who should consider this trial
Good fit: Ideal candidates are older adults from low socioeconomic backgrounds who have not previously been diagnosed with cognitive deficits and have received care from Oak Street Health.
Not a fit: Patients who have already been diagnosed with cognitive impairments or dementias will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier detection and better management of cognitive impairment in underserved communities, improving patient outcomes.
How similar studies have performed: Other studies have shown promise in using technology for early detection of cognitive impairment, but this specific approach is novel in its focus on underserved populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * been seen by an Oak Street healthcare provider affiliated with one of the 24 enrolled practices * had at least one clinic visit (routine or Annual Wellness Visit) during the 3-year study period * not been diagnosed previously with cognitive deficits, impairments or dementias. Exclusion Criteria: * Children, adolescence, and younger adults are excluded as cognitive impairment in these populations is often due to differences other than age-related changes.
Where this trial is running
Chicago, Illinois
- Oak Street Health — Chicago, Illinois, United States (RECRUITING)
Study contacts
- Study coordinator: Michael S Wolf, PhD MPH
- Email: mswolf@northwestern.edu
- Phone: 312-503-5592
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Dementia, Cognitive Impairment, Cognitive Decline, Alzheimer Disease, Detect, Manage